HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 3 Days

×
68 articles summarized · Last updated: LATEST

Last updated: May 9, 2026, 11:30 AM ET

Sector Deal Activity & Portfolio Management

Private equity dealmaking across various sectors saw several strategic acquisitions, including FH Capital acquiring a majority stake in JinkoSolar’s U.S. subsidiary, while Amulet Capital purchased TFP Fertility Group, which operates an integrated network of 10 clinics across the UK and Poland. In healthcare IT, Silversmith-backed Med Tech snapped up Avarion, a provider of managed healthcare IT services in Valencia, California, and Frazier Healthcare-backed Care Tria acquired digital pharmacy Cary Health, signaling continued investment in decentralized medical services. Elsewhere, in services consolidation, PE-backed Pye-Barker scooped up AAA Fire Extinguisher Co., an Alpharetta, Georgia-based provider of fire protection services, and Brightstar invested in Simon Eye Holdings, where management retained a meaningful stake.

Energy and infrastructure deals also featured prominently, with Carlyle and Diversified Energy agreeing to acquire Andarko Basin oil assets from Camino for $1.2bn, securing over 100 undeveloped inventory locations in Oklahoma's active development area, while SVP acquired the New Frontera Holdings power generation facility following its 2021 restructuring. In a strategic shift, Siris Capital acquired renewable energy services provider Takkion from Apollo, which had originally purchased the company in 2020. In the specialized industrials space, Allied Industrial Partners invested in Trinity Industrial, a firm that will remain founder-led with management retaining significant equity.

Healthcare & Life Sciences Transactions

The healthcare vertical shows persistent M&A activity, particularly in fertility and specialized services, exemplified by Amulet Capital’s purchase of TFP Fertility Group. Furthermore, Sovereign-backed Bioscript expanded its consulting capabilities by snapping up Triducive, a firm specializing in clinical opinion publication for pharma companies. In ophthalmology, Brightstar invested in Simon Eye Holdings, with the CEO continuing to lead the firm alongside existing management. This activity contrasts with the broader market narrative, as Capstone Partners noted challenges in the industrials deal market while business services companies are actively being shopped by firms including Audax and Baird Capital.

AI, Tech Funding, and Corporate Bets

Venture investment remains heavily concentrated in artificial intelligence, with major players like Nvidia committing over $40bn to equity AI deals year-to-date, driving significant funding rounds across the ecosystem as seen this past week. Specific AI applications are attracting capital, such as Fazeshift raising $17M in Series A funding for its AI agents automating accounts receivable, and Norvestor acquiring Germany’s Debtist, a provider of AI-driven receivables management. In corporate venturing, Amex Ventures detailed its thesis focused on backing startups building "Autonomous Commerce," while Robinhood’s venture fund IPO attracted over 150,000 retail investors seeking exposure to private tech firms like OpenAI and Stripe.

Secondaries, Capital Deployment, and Investor Sentiment

Investor intentions suggest a focus on cautious deployment and sector-specific mandates, as Kiwoom Asset Management plans a risk-averse approach to North American and Western European fund allocations. Conversely, Montana Capital Partners is deploying $40m across fund, secondary, and co-investments, focusing on climate and social impact mandates. The secondaries market is experiencing a boom driven by geopolitical uncertainty, with sources noting that this volatility is fueling record activity, even as Munich Private Equity Partners' Hans-Christian Moritz describes the industry as coming to terms with a new liquidity reality in the five stages of CV grief. In Asia, Advantage seeks to double its AUM within a year following a strategic 5% equity sale to Pinnacle Investment Management in January.

Firm Strategy, Exits, and Personnel Moves

Firms are realizing substantial returns on select exits, notably Siris Capital preparing to triple its money on the sale of Equiniti, with co-founder Frank Baker pointing to future tokenized securities investments as a parallel opportunity. Simultaneously, firms are making strategic launches and internal promotions; GI Partners rolled out Rose Bio Solutions following the acquisition of Charles River Laboratories International’s CDMO business, and MiddleGround promoted Alexander van der Have to partner to expand its European footprint. Leadership changes across the industry include ICG appointing Brant Gresham to lead the US West and Felipe Sotomayor to oversee Latin America, while Vistria appointed John Atkinson as an operating partner for its financial services team, leveraging his experience from Marsh's fast-growing units.

Thematic Investment Focus: Defense & Fertility

Geopolitical tensions are shaping investment themes, with European defense tech startups being termed "the new wave," although Houlihan Lokey indicates the 'war effect' is complicating defense deal valuations, as evidenced by EQT’s third rejected offer for Intertek. In contrast, fertility services represent a clear growth area, with Amulet Capital acquiring TFP Fertility Group, which spans UK and Polish clinic networks. Meanwhile, the European EV infrastructure sector is pivoting from chargers to code, while European GPs are looking overseas, with firms like Mutares planning concrete steps toward opening a Houston office to capitalize on US deal flow, even as overall April deal value dropped after a strong first quarter according to S&P Global data.

Emerging Fund Strategies and Market Signals

New capital strategies are targeting underserved demographics and specific market niches. Mother Ventures successfully raised a $10M debut fund focusing on mothers as consumers, while the women-led Arāya Sie Fund secured a £7.5M first close amid a stated tech ‘bro renaissance.’ The market is also seeing capital being deployed in adjacent technology sectors; for instance, Quantum Motion raised $160M in a Series C round as the quantum sector gains traction. Furthermore, some established players are quietly adjusting their exposure; Fidelity has shut down its dedicated venture capital arm, according to sources, signaling a potential re-evaluation of direct VC exposure among large asset managers.